Similar Articles
221 Recent efficacy and long-term survival of Astragalus polysaccharide combined with gemcitabine and S-1 in pancreatic cancer
222 Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease: A promising future
223 Lenvatinib, sintilimab combined interventional treatment vs bevacizumab, sintilimab combined interventional treatment for intermediate-advanced unresectable hepatocellular carcinoma
224 Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway
225 Diabetes mellitus and comorbidities in elderly people from the Lugu community: A critical-reflective analysis
226 Bibliometric analysis of olaparib and pancreatic cancer from 2009 to 2022: A global perspective
227 Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: A case report
228 From biomarker discovery to combined therapies: Advancing hepatocellular carcinoma treatment strategies
229 MicroRNA-206 as a promising epigenetic approach to modulate tumor-associated macrophages in hepatocellular carcinoma
230 Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA